Chengdu Huasun Group Inc Ltd (000790) - Total Liabilities
Based on the latest financial reports, Chengdu Huasun Group Inc Ltd (000790) has total liabilities worth CN¥911.88 Million CNY (≈ $133.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Chengdu Huasun Group Inc Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Chengdu Huasun Group Inc Ltd - Total Liabilities Trend (1995–2024)
This chart illustrates how Chengdu Huasun Group Inc Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 000790 total asset value.
Chengdu Huasun Group Inc Ltd Competitors by Total Liabilities
The table below lists competitors of Chengdu Huasun Group Inc Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bhagiradha Chemicals & Industries Limited
NSE:BHAGCHEM
|
India | Rs4.22 Billion |
|
Holsin Engineering Consulting
SHG:603909
|
China | CN¥4.28 Billion |
|
Qingdao Richen Food Co Ltd
SHG:603755
|
China | CN¥350.17 Million |
|
Hung Ching Development & Construction Co Ltd
TW:2527
|
Taiwan | NT$14.47 Billion |
|
NanJing Sanchao Advanced Materials Co Ltd
SHE:300554
|
China | CN¥222.39 Million |
|
Palisade Bio Inc
NASDAQ:PALI
|
USA | $5.57 Million |
|
Mayur Uniquoters Ltd
NSE:MAYURUNIQ
|
India | Rs1.16 Billion |
|
The Anup Engineering Limited
NSE:ANUP
|
India | Rs-6.91 Billion |
Liability Composition Analysis (1995–2024)
This chart breaks down Chengdu Huasun Group Inc Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Chengdu Huasun Group Inc Ltd's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.98 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Chengdu Huasun Group Inc Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Chengdu Huasun Group Inc Ltd (1995–2024)
The table below shows the annual total liabilities of Chengdu Huasun Group Inc Ltd from 1995 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.18 Billion ≈ $172.86 Million |
+11.75% |
| 2023-12-31 | CN¥1.06 Billion ≈ $154.68 Million |
+57.41% |
| 2022-12-31 | CN¥671.56 Million ≈ $98.27 Million |
+81.66% |
| 2021-12-31 | CN¥369.68 Million ≈ $54.10 Million |
+62.45% |
| 2020-12-31 | CN¥227.56 Million ≈ $33.30 Million |
-11.73% |
| 2019-12-31 | CN¥257.78 Million ≈ $37.72 Million |
+3.71% |
| 2018-12-31 | CN¥248.55 Million ≈ $36.37 Million |
-48.98% |
| 2017-12-31 | CN¥487.19 Million ≈ $71.29 Million |
+14.58% |
| 2016-12-31 | CN¥425.19 Million ≈ $62.22 Million |
+24.14% |
| 2015-12-31 | CN¥342.50 Million ≈ $50.12 Million |
-20.39% |
| 2014-12-31 | CN¥430.24 Million ≈ $62.96 Million |
+0.91% |
| 2013-12-31 | CN¥426.37 Million ≈ $62.39 Million |
+16.51% |
| 2012-12-31 | CN¥365.96 Million ≈ $53.55 Million |
-1.04% |
| 2011-12-31 | CN¥369.79 Million ≈ $54.11 Million |
+19.81% |
| 2010-12-31 | CN¥308.63 Million ≈ $45.16 Million |
-0.17% |
| 2009-12-31 | CN¥309.15 Million ≈ $45.24 Million |
-16.33% |
| 2008-12-31 | CN¥369.49 Million ≈ $54.07 Million |
+27.32% |
| 2007-12-31 | CN¥290.20 Million ≈ $42.47 Million |
+7.12% |
| 2006-12-31 | CN¥270.92 Million ≈ $39.64 Million |
-5.56% |
| 2005-12-31 | CN¥286.87 Million ≈ $41.98 Million |
+16.89% |
| 2004-12-31 | CN¥245.43 Million ≈ $35.91 Million |
+36.20% |
| 2003-12-31 | CN¥180.20 Million ≈ $26.37 Million |
+8.69% |
| 2002-12-31 | CN¥165.79 Million ≈ $24.26 Million |
+12.14% |
| 2001-12-31 | CN¥147.83 Million ≈ $21.63 Million |
-11.70% |
| 2000-12-31 | CN¥167.42 Million ≈ $24.50 Million |
+25.13% |
| 1999-12-31 | CN¥133.80 Million ≈ $19.58 Million |
+45.71% |
| 1998-12-31 | CN¥91.82 Million ≈ $13.44 Million |
+134.84% |
| 1997-12-31 | CN¥39.10 Million ≈ $5.72 Million |
+79.92% |
| 1996-12-31 | CN¥21.73 Million ≈ $3.18 Million |
-13.74% |
| 1995-12-31 | CN¥25.19 Million ≈ $3.69 Million |
-- |
About Chengdu Huasun Group Inc Ltd
Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs; and medicines for the treatment of … Read more